Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Inflammation × Specimen Handling × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Prostatic Neoplasms 53 Lung Neoplasms 44 Leukemia, Myeloid, Acute 35 Carcinoma, Non-Small-Cell Lung 34 Breast Neoplasms 33 Pancreatic Neoplasms 22 Myelodysplastic Syndromes 21 Leukemia, Lymphocytic, Chronic, B-Cell 21 Multiple Myeloma 20 Colorectal Neoplasms 19 Neoplasm Metastasis 18 Carcinoma, Renal Cell 18 Melanoma 17 Ovarian Neoplasms 16 Lymphoma, Large B-Cell, Diffuse 15 Glioblastoma 15 Brain Neoplasms 15 Triple Negative Breast Neoplasms 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Leukemia, Myelomonocytic, Chronic 11 Squamous Cell Carcinoma of Head and Neck 10 Fallopian Tube Neoplasms 10 Carcinoma, Hepatocellular 10 Lymphoma, Follicular 9 Lymphoma, B-Cell 9 Urinary Bladder Neoplasms 8 Rectal Neoplasms 8 Oropharyngeal Neoplasms 8 Neoplasms 8 Myeloproliferative Disorders 8

Interventions

Exercise 5 salicylsalicylic acid 2 palbociclib 2 Vitamin D 2 Tea 2 Tablets 2 Surgical Procedures, Operative 2 Sufentanil 2 Spironolactone 2 Resistance Training 2 Oxycodone 2 Omeprazole 2 Nutrition Assessment 2 Metformin 2 Ketorolac 2 Ibuprofen 2 Fish Oils 2 Blood Specimen Collection 2 Aspirin 2 Ascorbic Acid 2 ziprasidone 1 soybean oil, phospholipid emulsion 1 semaglutide 1 montelukast 1 microcrystalline cellulose 1 ginger extract 1 falcarinol 1 falcarindiol 1 epigallocatechin gallate 1 dapagliflozin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡